Inhibitory effects of statins on human monocarboxylate transporter 4.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International journal of pharmaceutics

• Publication date

  2006-07-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.IJPHARM.2006.02.043PMID 16621368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transport mechanism for L-lactic acid in human myocytes using human prototypic embryonal rhabdomyosarcoma cell line (RD cells).

  2005cited by this paper
• Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.

  2004cited by this paper
• The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond

  2004cited by this paper
• Mechanism of L-lactic acid transport in L6 skeletal muscle cells.

  2004cited by this paper
• Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors.

  2004cited by this paper
• Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis

  2003cited by this paper
• Transport mechanism for lovastatin acid in bovine kidney NBL-1 cells: kinetic evidences imply involvement of monocarboxylate transporter 4.

  2003cited by this paper
• Statin-associated myopathy.

  2003cited by this paper
• Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle

  2002cited by this paper
• Myopathy and rhabdomyolysis with lipid-lowering drugs.

  2002cited by this paper
• Evaluation of myopathy risk for HMG-CoA reductase inhibitors by urethane infusion method.

  2002cited by this paper
• Blocking of acidosis-mediated apoptosis by a reduction of lactate dehydrogenase activity through antisense mRNA expression.

  2001cited by this paper
• MCT1-Mediated Transport of L-Lactic Acid at the Inner Blood–Retinal Barrier: A Possible Route for Delivery of Monocarboxylic Acid Drugs to the Retina

  2001cited by this paper
• Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics.

  2000cited by this paper
• Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle

  2000cited by this paper
• Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.

  2000cited by this paper
• Atorvastatin Transport in the Caco-2 Cell Model: Contributions of P-Glycoprotein and the Proton-Monocarboxylic Acid Co-Transporter

  2000cited by this paper
• Lactic Acid Efflux from White Skeletal Muscle Is Catalyzed by the Monocarboxylate Transporter Isoform MCT3*

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

  1995cited by this paper
• Management of primary hyperlipidemia.

  1995cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Transport of statins by multidrug resistance-associated proteins 1 and 5.

  2025cites this paper
• Lactate and lactylation in tumor immunity

  2025cites this paper
• Association between the Expression of Monocarboxylate Transporters in Tumors and Surrounding Stromal Cells and Cancer Prognosis: A Meta-Analysis.

  2025cites this paper
• Dual role of lactate in ferroptosis: Mechanisms, pathophysiology and therapeutic opportunities (Review)

  2025cites this paper
• Statins affect human iPSC-derived cardiomyocytes by interfering with mitochondrial function and intracellular acidification

  2024cites this paper
• Exploring monocarboxylate transporter inhibition for cancer treatment

  2024cites this paper
• The emerging role of lactate in tumor microenvironment and its clinical relevance.

  2024cites this paper
• Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts

  2024cites this paper
• Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4

  2023cites this paper
• Tumor lactic acid: a potential target for cancer therapy

  2023cites this paper
• Modulation of glucose metabolism through macrophage-membrane-coated metal-organic framework nanoparticles for triple-negative breast cancer therapy

  2023cites this paper
• NIR‐Activatable Heterostructured Nanoadjuvant CoP/NiCoP Executing Lactate Metabolism Interventions for Boosted Photocatalytic Hydrogen Therapy and Photoimmunotherapy

  2023cites this paper
• Statins and Cardiomyocyte Metabolism, Friend or Foe?

  2023cites this paper
• Lactate in the tumor microenvironment: A rising star for targeted tumor therapy

  2023cites this paper
• Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)

  2022cites this paper
• Combining metformin with lactate transport inhibitors as a treatment modality for cancer - recommendation proposal

  2022cites this paper
• Tumor Cell-Derived Microparticles packaging Monocarboxylate Transporter4 Inhibitor Fluvastatin suppress Lung Adenocarcinoma via Tumor Microenvironment Remodeling and improve Chemotherapy

  2022cites this paper
• Tumor Metabolism: Focused on Tumor Glycolysis, Progress, and Prospects in Cancer Therapy

  2021cites this paper
• Serpinc1 Acts as a Tumor Suppressor in Hepatocellular Carcinoma Through Inducing Apoptosis and Blocking Macrophage Polarization in an Ubiquitin-Proteasome Manner

  2021cites this paper
• Transport function, regulation, and biology of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4).

  2021cites this paper
• Visual analysis on the research of monocarboxylate transporters based on CiteSpace

  2021cites this paper
• Pharmacological interventions part IV: Metabolic modifiers

  2020cites this paper
• Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease

  2020cites this paper
• A MSN-based tumor-targeted nanoplatform to interfere with lactate metabolism to induce tumor cell acidosis for tumor suppression and anti-metastasis.

  2020cites this paper
• Targeting the pH Paradigm at the Bedside: A Practical Approach

  2020cites this paper
• SLC16 Family: From Atomic Structure to Human Disease.

  2020cites this paper
• Targeted sensitization of tumor cells for radiation through monocarboxylate transporters 1 and 4 inhibition in vitro

  2020cites this paper
• Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition.

  2019cites this paper
• Monocarboxylate transporters in cancer

  2019cites this paper
• Geranylgeraniol Prevents Statin-Dependent Myotoxicity in C2C12 Muscle Cells through RAP1 GTPase Prenylation and Cytoprotective Autophagy

  2018cites this paper
• [Direct mechanism of action in toxic myopathies].

  2017cites this paper
• Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells

  2017cites this paper
• Myotoxicity of statins: Mechanism of action

  2017cites this paper
• Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer.

  2017cites this paper
• Intracellular Hyper-Acidification Potentiated by Hydrogen Sulfide Mediates Invasive and Therapy Resistant Cancer Cell Death

  2017cites this paper
• Targeting MCT4 for treatment of advanced prostate cancers : inhibiting cell proliferation and enhancing anticancer immunity through suppressing lactic acid secretion and elevated glycolysis

  2017cites this paper
• Mécanismes d’action directs mis en jeu dans les myopathies toxiques

  2017cites this paper
• Effect of Statins on Functional Expression of Membrane Transporters in L6 Rat Skeletal Muscle Cells

  2016cites this paper
• Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity.

  2016cites this paper
• Muscle rupture associated with statin use.

  2016cites this paper
• Cancer: fundamentals behind pH targeting and the double-edged approach

  2016cites this paper
• Interaction of atorvastatin with the human glial transporter SLC16A1.

  2016cites this paper
• Simvastatin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cites this paper
• Mechanism of Drug-induced Side Effects and Disease Involving Monocarboxylate Transporter 4

  2016cites this paper
• Brain cholesterol and the role of statins in neuroprotection

  2016cites this paper
• Uptake Transport at the BBB—Examples and SAR

  2015cites this paper
• Investigation of the association between genetics, drug exposure and statin-induced muscle toxicity

  2015cites this paper
• [Role of Monocarboxylate Transporter in Statin-induced Cytotoxicity].

  2015cites this paper
• Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies.

  2014cites this paper
• Role of monocarboxylate transporters in drug delivery to the brain.

  2014cites this paper
• Statins and Neuroprotection: Basic Pharmacology Needed

  2014cites this paper
• Decreased Astroglial Monocarboxylate Transporter 4 Expression in Temporal Lobe Epilepsy

  2014cites this paper
• Monocarboxylic Acid Transporters

  2014cites this paper
• Monocarboxylate transporters as targets and mediators in cancer therapy response.

  2014cites this paper
• Mechanisms and assessment of statin‐related muscular adverse effects

  2014cites this paper
• Diagnostic and Prognostic Value of Lactate Transporters in Prostate Cancer

  2013cites this paper
• Targeting lactate metabolism for cancer therapeutics.

  2013cites this paper
• Regulation of multidrug resistance protein 2 (MRP2, ABCC2) expression by statins: involvement of SREBP-mediated gene regulation.

  2013cites this paper
• Crucial Residue Involved in L-Lactate Recognition by Human Monocarboxylate Transporter 4 (hMCT4)

  2013cites this paper
• DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome

  2013cites this paper
• Anticancer Agents That Counteract Tumor Glycolysis

  2012cites this paper
• Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC).

  2012cites this paper
• Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in‐vitro kinetic parameters for the prediction of clinically relevant drug–drug interactions

  2012influential citation
• Role of monocarboxylate transporters in human cancers: state of the art

  2012cites this paper
• [Effects of acidification and alkalinization agents on statins-induced muscle toxicity].

  2012cites this paper
• Regulation mechanism of ABCA1 expression by statins in hepatocytes.

  2011cites this paper
• AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscle.

  2011cites this paper
• Prodrugs Designed to Target Transporters for Oral Drug Delivery

  2011cites this paper
• Monocarboxylate transporters as potential therapeutic targets in breast cancer : inhibition studies in vitro models

  2011cites this paper
• Isolation, structure and cholesterol esterase inhibitory activity of a polysaccharide, PS-A, from Cordyceps sinensis

  2010cites this paper
• Regulation of monocarboxylate transporter 1 in skeletal muscle cells by intracellular signaling pathways.

  2010cites this paper
• Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies.

  2010cites this paper
• Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.

  2009cites this paper
• Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy

  2009cites this paper
• Uptake of phenoxyacetic acid derivatives into Caco-2 cells by the monocarboxylic acid transporters.

  2009cites this paper
• The SLC16 monocaboxylate transporter family.

  2008cites this paper
• Focus on the Fundamentals: Toward Better Therapeutic Index Prediction

  2008cites this paper
• A Pivotal Role for Interleukin-4 in Atorvastatin-associated Neuroprotection in Rat Brain*

  2008cites this paper
• Association between risk of myopathy and cholesterol-lowering effect: a comparison of all statins.

  2008cites this paper
• Evolution and functional divergence of monocarboxylate transporter genes in vertebrates.

  2008cites this paper
• Bicarbonate supplementation as a preventive way in statins-induced muscle damage.

  2008cites this paper
• The SLC16 monocaboxylate transporter family

  2008cites this paper
• Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse γ-Hydroxybutyric Acid

  2008cites this paper
• Preventive effects of bicarbonate on cerivastatin-induced apoptosis.

  2007cites this paper